(Q44495190)

English

Pre-transplant (18)F-fluorodeoxyglucose positron emission tomography-based survival model in patients with aggressive lymphoma undergoing high-dose chemotherapy and autologous SCT.

scientific article published on 10 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Pre-transplant (18)F-fluorodeoxyglucose positron emission tomography-based survival model in patients with aggressive lymphoma undergoing high-dose chemotherapy and autologous SCT. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

S Akhtar

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

A S Al-Sugair

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

M Abouzied

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Y Alkadhi

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

M Dingle

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

M Abdelsalam

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

H Soudy

7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

A Darwish

8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

A Eltigani

9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

T A M Elhassan

10

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

M Nabil-Ahmed

11

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

I Maghfoor

12

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

10 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

551-556

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

21 January 2018

Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

21 January 2018

Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

21 January 2018

Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

21 January 2018

The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

21 January 2018

Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

21 January 2018

Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

21 January 2018

Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

21 January 2018

Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

21 January 2018

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

21 January 2018

A Proportional Hazards Model for the Subdistribution of a Competing Risk

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

21 January 2018

ESHAP + fixed dose G-CSF as autologous peripheral blood stem cell mobilization regimen in patients with relapsed or refractory diffuse large cell and Hodgkin's lymphoma: a single institution result of 127 patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

21 January 2018

Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of pre- and post-transplantation positron emission tomography using 18-fluorodeoxyglucose on poor-prognosis lymphoma patients undergoing autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression modeling of competing risk using R: an in depth guide for clinicians

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

7 January 2021

based on heuristic

inferred from DOI database lookup

(18)F-deoxyglucose PET: useful in the management of patients with stem cell transplantation for lymphoma?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

7 January 2021

based on heuristic

inferred from DOI database lookup

Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell t

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.168

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2012.168

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44495190&oldid=2206687565"